Bevenopran

DB12464InvestigationalSmall molecule

Bevenopran has been used in trials studying the treatment of Renal Impairment and Opioid-Induced Constipation.

Chemical structure of Bevenopran
Mechanism
Curator reviewed
Formula / weight
C20H26N4O4 · 386.452 g/mol (avg)
Code names
ADL-5945 · CB-5945

Resolves to

Compound
UNIIIC58Q2EHPJCAS676500-67-7ChEMBLCHEMBL3039511PubChem10452732
Structure
InChIKeyZGCYVRNZWGUXNQ-UHFFFAOYSA-NSMILESCOC1=CC(CNCCC2CCOCC2)=CC=C1OC1=CN=C(C=N1)C(N)=O
Targets
P35372OPRM1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Bevenopran, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In